Tag: Cardiovascular disease

With up to 80% of patients failing to achieve blood pressure targets, medication adherence is a major challenge [1.2.3]. So, **what is the new injection for high blood pressure?** It's an investigational drug called Zilebesiran, offering a potential twice-yearly dosing schedule [1.2.3].

A meta-analysis of studies involving 1,835 patients receiving vasopressors via peripheral intravenous catheters (PIVs) found a complication prevalence of about 8.6% [1.9.1]. Understanding what are the contraindications for vasoconstriction is crucial for patient safety.

High blood pressure affects more than 40% of adults over 25 worldwide, and many of these individuals also require treatment for high cholesterol. In most cases, you can take statins and blood pressure pills at the same time, and this combination is often medically recommended to effectively manage cardiovascular risk.

According to the Mayo Clinic, the symptoms of heartburn and a heart attack can be so similar that it can be difficult to tell them apart. Understanding the crucial differences is vital, as self-treating potential heart-related chest pain with Tums can delay lifesaving medical attention.

According to the Mayo Clinic, a prescription combination of aspirin and omeprazole is used for patients who need aspirin to prevent heart and blood vessel problems but are also at high risk of developing stomach ulcers. When taken under a doctor’s supervision, a patient can take aspirin with omeprazole to benefit from both medications while mitigating gastrointestinal risks.

According to a 2020 analysis published in *PLoS Medicine*, long-term oral glucocorticoid use, even at low doses, is associated with an increased risk of adverse cardiovascular events, including stroke. This means that for individuals taking the medication, the question of 'Can prednisolone cause stroke?' is a serious consideration for both patients and healthcare providers.

In cases of acute myocardial infarction (MI) where primary percutaneous coronary intervention (PCI) is unavailable or delayed, timely reperfusion therapy with a thrombolytic agent is critical for survival. The choice of agent can significantly impact outcomes, so what is the best thrombolytic agent for MI, and what are the key differences between modern options?

With an estimated 40,000 tonnes consumed annually, aspirin is one of the most widely used medications in the world. A versatile drug, understanding what are three common indications for aspirin is key to appreciating its broad therapeutic applications and different uses.

According to American Heart Association guidelines, fibrinolytic therapy is explicitly not recommended for treating non–ST-elevation myocardial infarction (NSTEMI) patients. When managing NSTEMI, healthcare professionals must be aware of not only the recommended treatments but also the medications that are contraindicated in Nstemi due to potential for harm. This critical distinction is based on the underlying pathophysiology of NSTEMI and is essential for optimizing patient outcomes and minimizing severe complications, particularly bleeding and worsening cardiac function.

While commonly viewed as a safe alternative to NSAIDs for pain relief, a 2022 study published in *Circulation* found that regular, high-dose acetaminophen use significantly increases blood pressure in hypertensive individuals, raising new questions about whether and how **Tylenol can cause a stroke**. This shifts the long-held perception of its cardiovascular safety, prompting a reevaluation, particularly for vulnerable populations.